Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Neuroblastoma 29Ganglioneuroblastoma 7Osteosarcoma 4Small Cell Lung Carcinoma 1Sarcoma, Ewing 1Rhabdomyosarcoma, Embryonal 1Rhabdomyosarcoma, Alveolar 1Rhabdomyosarcoma 1Rhabdoid Tumor 1Neoplasms 1Neoplasm, Residual 1Medulloblastoma 1Leiomyosarcoma 1Glioma 1Glioblastoma 1Ependymoma 1Diffuse Intrinsic Pontine Glioma 1Brain Neoplasms 1Bone Neoplasms 1

Interventions

Vinorelbine 2Vincristine 2Radiotherapy 2Radiation 2Dactinomycin 2Cyclophosphamide 2temsirolimus 1ganitumab 1efineptakin alfa 1dinutuximab 1X-Rays 1TB-403 1Specimen Handling 1Sirolimus 1Saline Solution 1Receptor Protein-Tyrosine Kinases 1Phantoms, Imaging 1Magnetic Resonance Spectroscopy 1Irinotecan 1Dasatinib 1Crizotinib 1Biopsy 1Biological Factors 1BAY 1895344 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Rhabdomyosarcoma, Alveolar × dinutuximab × Clear all
NCT06669013 2024-11-01

FollowTheDIN

N.N. Petrov National Medical Research Center of Oncology

Phase 3 Recruiting
40 enrolled
Sarcoma

Bone Neoplasms, Rhabdomyosarcoma, Alveolar, Rhabdomyosarcoma, Embryonal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡